QuidelOrtho

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho

Retrieved on: 
Donnerstag, Mai 30, 2024
COVID-19, News, Advertising, FDA, QuidelOrtho, Defendant, LLP, Court, Savanna, Complaint, Pharmaceutical industry

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding QuidelOrtho’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
  • To learn more about the QuidelOrtho class action, go to www.faruqilaw.com/QDEL or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important June 11 Deadline in Securities Class Action - QDEL

Retrieved on: 
Mittwoch, Mai 29, 2024
Titan, COVID-19, Class, QuidelOrtho, Advertising, Plaintiff, Court, Savanna

WHAT TO DO NEXT: To join the QuidelOrtho class action, go to https://rosenlegal.com/submit-form/?case_id=22828 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the QuidelOrtho class action, go to https://rosenlegal.com/submit-form/?case_id=22828 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than June 11, 2024.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Ocugen, Sonder, and QuidelOrtho Innovations and Encourages Investors to Contact the Firm

Retrieved on: 
Donnerstag, Mai 30, 2024
Employment, COVID-19, Organization, HireRight, News, Risk, Food, FDA, Diagnosis, QuidelOrtho, Bank statement, Sale, Publication, Form, Infection, Prospectus, IPO, Hold, Defendant, Complaint, Annual report, P.C, Register, Alpha, Risk management, Sonder, HRT, Security (finance)

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • That same day, pursuant to the Offering Documents, HireRight’s common stock began publicly trading on the New York Stock Exchange (“NYSE”) under the ticker symbol HRT.
  • On this news, the price of QuidelOrtho stock dropped $4.85, or more than 10 percent, to close at $42.15 on April 2, 2024.
  • For more information on the QuidelOrtho class action go to: https://bespc.com/cases/QDEL

DEADLINE ALERT for HRT, CKPT, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Mittwoch, Mai 29, 2024
Employment, COVID-19, Class, HireRight, Risk, Investment, Suite, FDA, Telephone, QuidelOrtho, Bank statement, Checkpoint, IPO, Annual report, Law, BLA, Savanna, ROU

BENSALEM, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

DEADLINE ALERT for SOND, OCGN, VFS, and QDEL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Mittwoch, Mai 29, 2024
COVID-19, Investment, Suite, QuidelOrtho, Bank statement, VinFast, Defendant, Annual report, Law, Savanna, ROU, Security (finance)

LOS ANGELES, May 29, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, May 29, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important June 11 Deadline in Securities Class Action - QDEL

Retrieved on: 
Dienstag, Mai 28, 2024
Titan, COVID-19, Class, QuidelOrtho, Advertising, Plaintiff, Court, Savanna

WHAT TO DO NEXT: To join the QuidelOrtho class action, go to https://rosenlegal.com/submit-form/?case_id=22828 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the QuidelOrtho class action, go to https://rosenlegal.com/submit-form/?case_id=22828 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than June 11, 2024.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

QDEL INVESTOR ALERT: Kirby McInerney LLP Alerts QuidelOrtho Corporation Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

Retrieved on: 
Dienstag, Mai 28, 2024
COVID-19, QuidelOrtho, News, FDA, Complaint, LLP, Savanna, Pharmaceutical industry

Among other results, the Company’s Adjusted Earnings Per Share was 46% below the midpoint of Wall Street analysts’ expectations.

Key Points: 
  • Among other results, the Company’s Adjusted Earnings Per Share was 46% below the midpoint of Wall Street analysts’ expectations.
  • QuidelOrtho also lowered its annual endemic COVID-19 revenue forecast from the range of $200-$400 million to $200 million.
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Hagens Berman by June 11, 2024 Deadline to Join Class Action Against QuidelOrtho (QDEL)

Retrieved on: 
Dienstag, Mai 28, 2024
FY, Q4, EPS, FDA, COVID-19, QuidelOrtho, SAN, Hagens Berman, Pharmaceutical industry

SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now .
  • 2, 2024, QuidelOrtho announced that it withdrew its submission for the Savanna RVP4 Test because recent data failed to meet expectations.
  • Since Feb. 13, 2024, the price of QuidelOrtho shares has fallen $24.59, or nearly 37%, wiping out about $1.6 billion of shareholder value.
  • “We are investigating whether QuidelOrtho may have engaged in improper channel-stuffing and about the likelihood of FDA approval for the Savanna test,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

QUIDELORTHO CORPORATION (NASDAQ: QDEL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho Corporation Investors of Upcoming Deadline

Retrieved on: 
Dienstag, Mai 28, 2024
COVID-19, News, Advertising, FDA, QuidelOrtho, Court, District court, Complaint, Security (finance)

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

Key Points: 
  • NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
    Do you, or did you, own shares of QuidelOrtho Corporation f/k/a Quidel Corporation (NASDAQ: QDEL)?
  • Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of QuidelOrtho Corporation f/k/a Quidel Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL) between February 18, 2022 and April 1, 2024, inclusive (the “Class Period”).
  • Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL

Retrieved on: 
Dienstag, Mai 28, 2024
COVID-19, News, Citigroup, FDA, QuidelOrtho, Prior, Ext, Pomerantz, LLP, Action Replay, Court, Complaint, Pharmaceutical industry

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL).

Key Points: 
  • NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation (“QuidelOrtho” or the “Company”) (NASDAQ: QDEL).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether QuidelOrtho and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.